Tue. May 26th, 2026
Spread the love

June 2021 was the first time Stanley Oguamanam, a graphic designer based in Enugu State, heard of Oxford International Group, an investment company, through his friend who was working with the company at the time.

Stanley told EQToday that he got a flyer from his friend, who presented Oxford International Group as a duly registered investment company dealing in mortgage, agriculture, and oil and gas.

Then, on June 16, he invested N1 million in one of the company’s subsidiaries, Oxford Peak Platinum Agrovest, through Oxford Green Farms Ltd.

Payment receipt

READ ALSO: Oxford International Group Cuts Off Lagos Banker After ‘Stealing’ N3m From Her

“The Oxford Agrovest deals in commodities, including turmeric, ginger and pepper, and gives investors the choice of investing in any of the commodities through weekly, annual and monthly investment contracts,” Stanley said.

“I chose the 12-month tenure plan and anticipated receiving their capital by June 2022, as well as the RoI of N323,750, following a 7.5 percent administrative charge deduction.”

This investment has thrown Stanley into disappointment, as the company withheld his RoI and investment capital of N1 million.

When Stanley invested in the company’s agroinvestment plan in 2021, he got a deed of agreement, a post-dated cheque and an email to confirm him as an investor.

The deed of agreement

Postdated cheque

The agreement stated that Stanley would cash the cheque on June 16, 2022, when his investment would have reached its maturity. But he was in for a jawbreaking surprise.

He described his efforts to cash the cheque and get his N1 million this way: “After taking the post-dated cheque to Fidelity Bank in Enugu State on June 17, 2022, one day after the maturity date, the cheque was rejected. I took it again to my bank, United Bank for Africa (UBA), and it was also rejected.

“I tried calling my friend who worked there and had introduced me to the investment, and he told me to check my emails. I found that I had received a message earlier, advising me not to deposit this cheque into the bank because there was a problem with the company and that my money would be paid when it was due,” Stanley told EQToday.

“My friend also told me that the company encountered issues with the Securities and Exchange Commission (SEC), the authority responsible for regulating companies in March 2022, and this prevented the company from being able to access its bank account and disburse funds to the investors after that time.

“After some days, I got an email saying that they employed some law firm to get the company out of the problem and that investors were promised payment within six months.

Appeal letter from Oxford International

READ ALSO: ‘I Want My N5m Back’ — Another Victim of Oxfordgold Investment Company Speaks

“Six months passed, yet I did not receive anything from them. When I called the lawyer who prepared the deed of agreement, he asked me to scan and forward the post-dated cheque, which I did, but I still got nothing. I also called and emailed them with many of their email contacts and numbers for help because I needed money to pay my rent.

“I also tried to reach the company through its solicitors, but it’s been excuses upon excuses. When I contacted all the numbers the company gave us to call for information, they told us they were not working there anymore.”

On January 9, 2023, Oxford International sent Stanley an email, which contained information about the company’s plan. The company said that it had engaged the services of an external solicitor called Diesel Solicitors regarding the repayment of investors.

Email from Oxford International Group in January 2023

Stanley said he also sent someone to Oxfordgold’s head office in Lagos twice and the person got some numbers. His calls to these numbers yielded no positive information on when he would be paid.

READ ALSO: 2 Years After Investing a Million Naira in Oxfordgold Company, Lagos Resident Gets Only N150,000

When EQToday called the three numbers affiliated with Diesel Solicitors on Thursday, two were switched off. Awa Okere Esq, the owner of the third number, answered the call but said he was no longer working for Diesel Solicitors.

Similarly, when EQToday called all the five numbers Stanley obtained from Oxfordgold’s head office, they were all switched off. An email was subsequently sent to the company’s email addresses, but no response has been received.

When EQToday contacted Olisah Aligbe, whose name and phone number appeared on the deed of agreement as the company’s legal advisor, via WhatsApp on Thursday, he said his firm had been disengaged by the investment company.

“Our firm has been debriefed of this matter by the company. We also sent a notice with respect to the debriefing as well,” he wrote.
The post 3 Years After Taking N1m, Oxford International Group Hasn’t Paid Investor appeared first on Foundation For Investigative Journalism.

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.